Privium Fund Management (UK)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,000
Closed -$1.26M 92
2023
Q2
$1.26M Buy
+30,000
New +$1.21M 1% 33

Other funds holding SYNH

Privium Fund Management (UK)'s SYNH Position: Q3 2023 in Review

Privium Fund Management (UK) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 30,000 shares — an estimated $1.26M sold.

Privium Fund Management (UK) first reported a position in SYNH in Q2 2023 and held it in 1 quarter. The position peaked at $1.26M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Privium Fund Management (UK) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Privium Fund Management (UK) sold 30,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.26M.
  • Privium Fund Management (UK) first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
  • Privium Fund Management (UK)'s Syneos Health, Inc. Class A Common Stock position peaked at $1.26M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2023, filed 6 Nov 2023.